Diet changes can partly explain the high burden of asthma in industrialised nations. Findings from experimental studies have stimulated many observational studies of the association between vitamins (A, C, D, and E) or nutrients acting as methyl donors (folate, vitamin B 12 , and choline) and asthma. However, observational studies are susceptible to several sources of bias; well conducted randomised controlled trials (RCTs) are the gold standard to establish whether diet has an eff ect on asthma. Evidence from observational studies and a few RCTs strongly justifi es ongoing and future RCTs in three areas: vitamin D for the prevention or treatment of asthma, choline supplementation as adjuvant treatment for asthma, and vitamin E to prevent the detrimental eff ects of air pollution in patients with asthma. At present, insuffi cient evidence exists to recommend supplementation with any vitamin or nutrient acting as a methyl donor to prevent or treat asthma.
Introduction
Asthma is a major public health problem in the USA 1 and worldwide. 2 Whereas the prevalence of asthma in industrialised nations has reached a relative plateau (after a sharp rise from the 1960s to the 1990s), asthma prevalence has continued to increase in many non-industrialised countries.
1,2 The causes of this global asthma epidemic are largely unidentifi ed; they are probably multifactorial and might include changes in diet-eg, decreased consumption of fruits and vegetables and increased intake of refi ned grains, red meats, and saturated fats. 3 In this Review we examine evidence of a link between two groups of dietary components that have been extensively studied in connection with asthma: vitamins (A, C, D, and E) and nutrients acting as methyl donors (folate, vitamin B 12 , and choline). In view of the fact that atopy (allergic sensitisation) is common in individuals with asthma, particularly children, we also review fi ndings for atopy or atopic diseases (eg, atopic dermatitis) where applicable.
Vitamins with antioxidant properties and asthma

Vitamin A
Oxidative stress, resulting from an imbalance between reactive oxidant species and antioxidants, can lead to tissue damage, airway infl ammation, abnormal immune responses, 4,5 and increased asthma severity. 6 Antioxidant defences include endogenous antioxidant enzymes and exogenous agents from the diet. Serum concentrations of antioxidants have been positively associated with forced expiratory volume in 1 s (FEV 1 ) in people with and without asthma. 7, 8 Vitamin A contributes to key biological processes in human beings, including growth, vision, epithelial diff erentiation, reproduction, and immune responses. 9 The two dietary sources of this vitamin are pre-formed vitamin A (retinol) and pro-vitamin A (carotenoids). 10 Dietary intake of retinol comes from animal sources (eg, whole milk, liver, and eggs) and fortifi ed foods. Orangeyellow fruits and vegetables (eg, carrots) are the main dietary sources of carotenoids, including α-carotene, β-carotene, and β-cryptoxanthins.
Oxidative stress might exacerbate asthma by increasing the release of pro-infl ammatory cytokines, airway infl ammation, and airway responsiveness. 4, 5, 11 Vitamin A might improve prevention or treatment of asthma by downregulation of oxidative stress 12 or via direct eff ects on the immune system. 13 For example, vitamin A downregulates T-helper (Th)2 (pro-allergic) immune responses by increasing proliferation of T-regulatory cells 14, 15 and inhibiting Th17 (pro-infl ammatory) cells. 16 However, vitamin A also enhances Th2 immune responses (eg, interleukin 4 expression). 17 Carotenoids might promote balanced Th1 or Th2 immune responses, 18 and lycopene supplementation reduces allergic airway infl ammation, 19 decreases concentrations of circulating interleukin 4 and interleukin 5, 19 and increases interferon-γ expression 20 in murine models. In 2009, Allen and colleagues 21 undertook a systematic review and (when methodologically appropriate) a meta-analysis of 21 observational studies of dietary intake or serum concentration of vitamin A (or its components) and asthma outcomes in children and adults (not including studies of prenatal diet or prenatal antioxidant levels). Self-reported dietary intake of vitamin A or its components (retinol and carotenoids) was inversely associated with asthma (diff erence for comparison of cases vs controls-182 μg per day, 95% CI -288·4 to -75·3) and asthma severity (diff erence for comparison of severe vs mild disease -344 μg per day, 95% CI -575·2 to -112·6). However, dietary intake of vitamin A was not signifi cantly associated with wheeze or airway responsiveness. 21 In 2010, Nurmatov and colleagues 22 examined pre-natal and post-natal dietary intake or serum concentration of Review vitamin A and its components as part of a systematic review and meta-analysis of observational studies of diet or nutrients for the primary prevention of asthma and allergy in children younger than 17 years. 22 For vitamin A and its components, evidence from 17 studies (including three birth cohorts) was deemed methodologically weak but possibly supportive of an eff ect on asthma but not on wheeze. For carotenoids, fi ndings from two birth cohort studies showed no signifi cant association between maternal dietary intake during pregnancy and wheeze or asthma in the child by the age of 2 years (when a confi dent diagnosis of asthma is not possible). [23] [24] [25] Since the publication of these two systematic reviews, 21, 22 investigators of a longitudinal study of 17 528 Norwegian adults (aged 19-55 years) noted that daily consumption of cod liver oil (containing vitamin A [1000 μg/5 mL] and vitamin D [400 IU/5 mL]) was signifi cantly associated with increased odds of incident asthma over a follow-up of 11 years (adjusted odds ratio [OR] 1·6, 95% CI 1·3-2·0). 26 Limitations of this study include potential selection bias (about 26% of participants had missing data for cod liver oil intake), exclusion of children, and possible residual confounding by cigarette smoking or vitamin D intake.
No primary randomised controlled trial (RCT) of vitamin A for the prevention or treatment of asthma has been done. However, Checkley and colleagues 27 did a secondary analysis in subgroups of Nepalese adults and children participating in two RCTs of vitamin A supplementation (administered for 16 months) to prevent mortality in children younger than 6 years, and vitamin A or β-carotene supplementation during pregnancy to prevent pregnancy-related mortality. In this analysis, neither vitamin A nor β-carotene supplementation (to preschool children [n=3879] or pregnant women [n=1551]) was signifi cantly associated with asthma or wheeze (at adolescence or young adulthood in the fi rst trial, and at school age in the second trial). Although the investigators had previously reported that vitamin A supplementation during pregnancy leads to increased lung function (FEV 1 and forced vital capacity [FVC] ) in school-aged Nepalese children, 28 they recorded no signifi cant results for FEV 1 or FVC (a marker of airfl ow obstruction and asthma severity 29 ) in their new analysis. This study was limited by potential selection bias due to loss of follow-up (ranging from about 18% to about 40%), variability in the dose given to pre-school children, and possible confounding by additional vitamin A supplementation received as part of a nationwide programme.
Higher intake of tomatoes, carrots, and leafy vegetables (which are rich in carotenoids such as α-carotene, β-carotene, lutein, and zeaxanthin) has been associated with lower prevalence of asthma in women. 30 Of the provitamin A carotenoids, β-carotene has been most intensely studied because of its protective properties against the eff ects of free radicals and oxidative damage. A metaanalysis of fi ve observational studies showed that high dietary intake of β-carotene was not signifi cantly associated with asthma or FEV 1 . 31 However, this meta-analysis was limited by sample size and residual confounding. Results of two RCTs showed that modifi cation of dietary intake of carotenoids or lycopene through a diet rich in fruits and vegetables 32 or (lycopene-rich) tomato extract and tomato juice 33 improved indicators of asthma control, including lung function measures and time to disease exacerbations in adults with asthma. Larger RCTs (including both children and adults) with longer follow-up are needed to further validate these fi ndings.
Vitamin C
Vitamin C (ascorbic acid), a potent water-soluble antioxidant found in various fruits and vegetables, has been associated with lower risks of cardiovascular disease, stroke, and cancer. 34 An anti-infl ammatory role for vitamin C is further supported by the fi nding that vitamin C supplementation reduces C-reactive protein (CRP) in individuals with raised CRP concentrations. 35 Vitamin C could have benefi cial eff ects on asthma through its immune-modulatory (eg, prostaglandin inhibition), antioxidant, or anti-infl ammatory properties. In experimental models, vitamin C has been linked to decreased airway responsiveness, and reduced peri vascular and peribronchiolar infi ltration by infl ammatory cells. 36, 37 In support of this hypothesis, results of a cross-sectional study of Turkish children showed reduced plasma concentrations of vitamin C (and other non-enzymatic antioxidants such as vitamin E and carotenoids) in patients with asthma. 38 Similarly, an increase of 1 standard deviation in serum concentrations of vitamin C and other non-enzymatic antioxidants (eg, β-carotene and selenium) was associated with a reduction in asthma prevalence in a study of US children. 39 In their systematic review and meta-analysis of 32 observational studies in children and adults, Allen and colleagues 21 reported that low dietary intake of vitamin C (variably defi ned across studies as lowest tertile or quintile, or as a low intake level [eg, <56 or <60 mg per day]) was signifi cantly associated with slightly increased odds of asthma (OR 1·12, 95% CI 1·04-1·20), with generally consistent results for wheeze and airway responsiveness, but null fi ndings for asthma severity. 21 Conversely, Nurmatov and colleagues 22 reported methodologically weak and unsupportive evidence of an eff ect of vitamin C on the development of asthma or atopy in their review of 14 studies (including three birth cohorts). 22 The discrepant conclusions of these two meta-analyses are probably connected to major diff erences in the criteria for study inclusion-eg, Allen and colleagues' study did not include birth cohorts. After publication of these reviews, investigators of a cross-sectional study of 1964 Greek children aged 1-3 years reported that dietary intake of vitamin C was signifi cantly and inversely associated with wheeze, but not with asthma. 40 
Review
In 2009, a Cochrane review of nine RCTs (aggregate sample size of 330 participants) of vitamin C supplementation and asthma outcomes (symptoms, lung function measures, total IgE, or use of inhaled steroids) concluded that insuffi cient evidence exists to recommend a role for vitamin C in the treatment of asthma. 41 No primary RCT of vitamin C supplementation to prevent asthma has been done. However, investigators of a secondary analysis of an RCT of vitamin C (1000 mg) and vitamin E (400 IU RRR α-tocopherol) supplementation to prevent pre-eclampsia in pregnant women recorded no signifi cant eff ects on asthma or respiratory symptoms in the off spring of participants at age 2 years 42 Longer follow-up of children participating in this study could further understanding of the association between vitamin C and childhood asthma.
Vitamin E
Vitamin E comprises several fat-soluble components with distinct antioxidant properties.
10 Vitamin E occurs naturally in eight chemical forms-α, β, γ, and δ-tocopherol, and α, β, γ, and δ-tocotrienol-of which α-tocopherol has the greatest bioavailability. Dietary sources of vitamin E include nuts, seeds, green vegetables, and vegetable oils. Vitamin E might help to prevent or treat asthma by downregulating oxidative stress, airway infl ammation, and Th2-immune responses (eg, reducing production of interleukin 4 by human peripheral blood mononuclear cells).
13, 43 The antioxidant and anti-infl ammatory properties of vitamin E are supported by fi ndings from an unblinded trial, which showed that administration of a vitamin E isoform (d-α-tocopherol) for 16 weeks reduced F 2 isoprostanes (a marker of oxidative stress) in bronchoalveolar lavage fl uid and airway responsiveness to methacholine (but not to specifi c allergens) in adults with mild atopic asthma. 44 Notably, plasma γ-tocopherol is inversely associated with total IgE and allergic sensitisation in adults. 45, 46 In their review and meta-analysis of 24 observational studies of vitamin E in children and adults, Allen and colleagues 21 reported a signifi cant association between low self-reported dietary intake and physician-diagnosed asthma (diff erence for comparison of cases and controls -1·91 mg per day, 95% CI -2·5 to -1·3 mg per day) but not with self-reported asthma, wheeze, or airway responsiveness. Lower dietary intake (but not serum concentration) of vitamin E was also signifi cantly associated with increased asthma severity. 21 From a review of 15 observational studies (including three birth cohorts), Nurmatov and colleagues 22 concluded that the evidence linking vitamin E intake during pregnancy to wheeze or asthma in childhood was methodologically weak but suffi ciently supportive of a potential eff ect, warranting follow-up in clinical trials.
Pearson and colleagues 47 showed no eff ect of vitamin E supplementation (500 mg per day) for 6 weeks on airway responsiveness in an RCT in 72 British adults with asthma. Consistent with this lack of eff ect of vitamin E on asthma morbidity, investigators of a second RCT reported that an antioxidant supplement (containing β-carotene, vitamin C, and vitamin E) had no eff ect on plasma F 2 isoprostanes, exhaled nitric oxide, or immune responses of peripheral blood mononuclear cells in 54 adults with allergy (defi ned as a doctor-diagnosed allergic rhinitis or asthma, and sensitisation to at least one allergen). 48 By contrast with these negative results, four RCTs have reported that vitamin E-containing antioxidants reduce ozone-induced bronchoconstriction in patients with 49, 50 and without 51, 52 asthma, which suggests a potential protective eff ect of vitamin E against the detrimental eff ects of ozone. Although no primary RCT of vitamin E supplementation to prevent asthma has been done, a secondary analysis of an RCT of vitamin C and vitamin E supplementation to prevent preeclampsia in pregnant women showed no eff ect on respiratory function in the off spring at age 2 years. 42 A question that remains outstanding is whether vitamin E obtained from foods has diff erent eff ects from vitamin E obtained from supplements. A pilot study confi rmed the feasibility of a food-based RCT to increase vitamin E intake to 15 mg per day in pregnant women; 53 However, whether this method of increasing vitamin E intake would yield better results than the use of supplements is unknown.
Vitamin D
Vitamin D is a nutrient and hormone that is key to the metabolism of calcium and phosphorus. Vitamin D is primarily acquired from sun exposure, with diet (eg, oily fi sh and dairy products) and supplements as secondary sources. Vitamin D status is assessed by measurement of the major circulating form of vitamin D-namely, serum or plasma 25-hydroxyvitamin D 3 (25[OH]D). 54 The terms vitamin D defi ciency (a serum concentration of 25 [OH]D <20 ng/mL) and vitamin D insuffi ciency (20-29 ng/mL) are commonly used, but an expert panel in the USA proposed a single threshold (≥20 ng/mL) as suffi cient for musculoskeletal health. 55 This threshold is controversial, however, because no consensus has been reached on vitamin D suffi ciency for non-musculoskeletal (eg, respiratory) health. 56 Irrespective of the threshold used, reduced serum or plasma vitamin D concentrations are commonly detected in children and adults in the USA, particularly in subgroups at high risk for asthma or asthma morbidity-eg, African Americans, Puerto Ricans, and obese people. 57, 58 Although the eff ects (if any) of vitamin D on asthma and asthma morbidity are not fully understood, they might include regulation of gene expression or immune responses (eg, upregulation of regulatory T cells 59 ), aff ecting lung development or function, preventing weight gain, 60 attenuating or preventing viral illness (a common cause of asthma exacerbations), and enhancing steroid responsiveness. 58 Of these potential eff ects, the Review most extensively studied are those on viral illnesses and steroid responsiveness. Findings from observational studies and RCTs suggest that vitamin D has a more consistent and stronger eff ect against viral respiratory illnesses in children [61] [62] [63] than in adults. 64 Results from observational and experimental studies [65] [66] [67] [68] [69] [70] also suggest that vitamin D insuffi ciency or defi ciency is associated with decreased steroid responsiveness. Consistent with fi ndings for viral illnesses, the eff ects of vitamin D on steroid responsiveness might be stronger in children than in adults. 71 In 2011, Paul and colleagues 58 reviewed the fi ndings of ten observational studies [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] (including seven birth cohorts [75] [76] [77] [78] [79] [80] [81] ) of dietary intake or serum concentration of vitamin D and asthma, concluding that evidence for a causal link is insuffi cient. Since then, investigators of six observational studies (two cross-sectional 82, 83 and four longitudinal, [84] [85] [86] [87] including two birth cohorts 84, 85 ) in children [83] [84] [85] [86] or adults 60, 82 have reported an inverse association 82, 83 or no association [84] [85] [86] [87] between serum or cord blood vitamin D concentration and asthma. Of the six published birth cohort studies that followed up at least 750 children each, one yielded negative results for asthma or wheeze at age 6 years, 85 whereas fi ve reported an inverse association between vitamin D status during pregnancy (assessed as maternal dietary intake, or maternal serum or cord blood vitamin D concentration) and wheeze [76] [77] [78] 80 or asthma 79 between the ages of 1·3 and 5 years. All these birth cohort studies had substantial loss of follow-up (ranging from around 24% to around 53%), which could have led to selection bias.
Three population-based studies (two cross-sectional 57, 88 and one longitudinal 70 ) showed an association between reduced serum vitamin D concentrations and severe disease exacerbations or core measures (eg, hospitalisations) of severe exacerbations in Costa Rican, North American, and Puerto Rican children with asthma. In the most recent of these studies, 57 vitamin D insuffi ciency or defi ciency (a serum 25 [OH]D concentration <30 ng/mL) was associated with increased odds of one or more severe asthma exacerbations in the previous year in Puerto Rican children, even after adjustment for household income, African racial ancestry, time spent outdoors, and other covariates. Notably, this association was stronger in non-atopic children (OR 6·2, 95% CI 2·1-21·2, p<0•01) than in atopic children (2·0, 95% 1·0-4·1, p=0·04), suggesting that vitamin D aff ects the risk of severe asthma exacerbations through mechanisms other than regulation of allergic immune responses-eg, modulation of viral illnesses or corticosteroid responses. Consistent with fi ndings for severe exacerbations in children with (predominantly) mild to moderate asthma, reduced vitamin D concentrations are associated with increased airway smooth muscle mass, decreased lung function, and worse disease control in children with severe, therapy-resistant asthma. 89 Results of ongoing RCTs of vitamin D supplementation during pregnancy to prevent asthma in childhood (NCT00920621, NCT00856947) or (as add-on therapy) treatment failure in adulthood (NCT01248065) have not yet been published. 58 In view of the present evidence, a clinical trial of vitamin D supplementation to prevent severe asthma exacerbations in school-aged children is both justifi able and necessary.
Nutrients acting as methyl donors
DNA methylation, a type of epigenetic regulation, is a mechanism underlying some gene-environment interactions on complex diseases such as asthma. 90 In particular, changes in DNA methylation can aff ect the pathogenesis of asthma by increasing or decreasing the expression of disease-susceptibility genes.
DNA methylation is catalysed by enzymes that transfer methyl groups (methyl-transferases) from the methylating agent S-adenosylmethionine to cytosine. In human beings, methyl donors for DNA methylation are mostly derived from dietary methyl groups. Folatedependent and choline-dependent pathways interact at the point that homocysteine is converted to methionine for derivation of S-adenosylmethionine. 91 In the fi rst pathway, tetrahydrofolates and vitamin B 12 are cofactors required by methionine synthase. In the second pathway, the methylation of homocysteine to form methionine is catalysed by betaine homocysteine methyltransferase. [91] [92] [93] Both transmethylation metabolic pathways closely interconnect with methyltetrahydrofolate, B 12 , choline, and methionine. Methyl donors aff ect DNA methylation and, potentially, immune responses (fi gure).
Folate, a type of water-soluble vitamin B and a cofactor (as tetrahydrofolates) in the transfer of one-carbon moieties, has a key role in aminoacid metabolism, purine and pyrimidine synthesis, and formation of S-adenosylmethionine. Dark leafy vegetables, fortifi ed cereals and bread are major dietary sources of folate. Folate defi ciency is associated with neural tube defects in embryos, macrocytic anaemia, cardiovascular diseases, and cancer. 94 Because of its known preventive eff ects against neural tube defects, folate supplements are routinely prescribed to women who are pregnant or planning to conceive. 95 Vitamin B 12 (cobalamin) is necessary for proper formation of red blood cells, neurological function, and DNA synthesis, and is found in meat (especially liver), poultry, fi sh and shellfi sh, eggs, milk, and milk products. Vitamin B 12 defi ciency is associated with neural tube defects, cardiovascular diseases, cognitive decline, macrocytic anaemia, and osteoporosis. 96 Choline is a lipotropic agent involved in several biological functions (eg, neurotransmitter production, signalling lipids, and components of structural membranes), and as a methyl group donor. 97 Dietary sources of choline include meat, liver, eggs, poultry, fi sh and shellfi sh, peanuts, and caulifl ower.
Review
Choline defi ciency is associated with neurological disorders, cardiovascular diseases, and infl ammation. 98 Nutrients acting as methyl donors could contribute to asthma risk by aff ecting DNA methylation and, ultimately, gene expression. In a mouse model, a maternal diet rich in methyl donors (including folic acid, vitamin B 12 , and choline) during pregnancy resulted in increased severity of allergic airway disease 99 in the F1 (off spring) generation and (to a lesser extent) the F2 generation. This dietary eff ect is probably mediated by dysregulation of lymphocyte maturation and enhancing Th2 immune responses. 99 This eff ect, in turn, is probably caused by DNA methylation of genes that are crucial to Th1 and Th2 immune balance (eg, Runx3, which is implicated in negative regulation of allergic airway disease in mice). 99 Although these fi ndings have generated substantial interest, their relevance to human beings is unclear because of the high doses of methyl donors used in the dietary intervention and scarcity of data supporting the eff ects of individual methyl donors (eg, folic acid).
To our knowledge, no animal models of the eff ects of exclusive folate intake or exclusive vitamin B 12 intake on experimental asthma (allergic airway disease) have been published. Intranasal or oral administration of choline, however, has been shown to reduce the number of eosinophils and reactive oxidant species in bronchoalveolar lavage fl uid in a murine model of allergic airway disease. 100 Together with fi ndings in adults 101, 102 and adolescents 102 with 101 and without 102 asthma, this suggests that choline might attenuate (and not enhance) allergic infl ammation in general and airway infl ammation in particular.
Results from experimental studies and the recommendation of folic acid supplementation in women who are pregnant or planning to conceive have triggered observational studies in children and adults. Because of their longitudinal design, birth cohort studies can best examine whether folate status or folic acid supplementation during pregnancy is associated with the development of asthma or atopy. However, not all birth cohort studies on this topic have gathered data for either maternal dietary intake or folate level in early pregnancy. 23, [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] Of these 11 studies, seven showed no signifi cant association between maternal folic acid intake (through diet and supplements) and asthma; 23, 103, 105, 107, 108, 110, 111 three of these negative studies had a short duration of follow-up, 23, 103, 111 (limiting their assessment of asthma, which is diffi cult before the age of 6 years) and the rest lost a large proportion of children to follow-up. Although Review the results of four birth cohort studies 104, 106, 111, 112 showed a positive association between folate status during pregnancy and asthma or atopy, they were limited by short duration of follow-up, non-comprehensive phenotypic assessment, or inconsistent results for asthma and atopy. The authors of the largest of these positive studies (n=32 077) noted that folic acid supplementation during pregnancy was associated with slightly increased risk of wheeze (adjusted relative risk 1·06, 95% CI 1·03-1·10) and lower respiratory tract infections in infancy. 104 Only three birth cohort studies have assessed biomarkers of folate. [110] [111] [112] In two of these studies, 110, 111 maternal folate status during pregnancy (assessed by measurement of plasma 111 or intracellular 110 folic acid concentration) was not associated with childhood asthma. In the third study, 112 maternal plasma folate concentration in the second trimester of pregnancy was signifi cantly and linearly associated with increased odds of asthma at age 3 years. However, none of these studies has separately measured folate species (vitamers). Whether folate status aff ects disease severity or control in people who already have asthma is unclear. 113 Two cross-sectional studies in adults yielded negative fi ndings for dietary intake or circulating concentration of vitamin B 12 and asthma or atopy. 114, 115 Additionally, investigators of two birth cohort studies reported no signifi cant association between maternal dietary intake or circulating B 12 concentration during pregnancy and wheeze in young children, yielding confl icting fi ndings for eczema or atopic dermatitis. 103, 111 We are not aware of published birth cohort studies of choline status during pregnancy and asthma or atopy.
No RCTs have been done on methyl donor supplementation during pregnancy to prevent asthma. This absence of research is understandable for folate because of weak and confl icting evidence from observational studies, and ethical concerns about withholding or reducing folic acid supplementation during conception or pregnancy because of its documented benefi cial eff ects. Although no RCTs of folate or vitamin B 12 supplementation to treat asthma have been published, Mehta and colleagues 101 did a 6-month RCT to examine the eff ects of choline supplementation (1500 mg, twice per day) on indicators of disease severity or control in 76 Indian adults with asthma. In this trial, choline supplementation led to reductions in symptoms, medication use, concentrations of cytokine (interleukin 4, interleukin 5, and tumour necross factor-α), and airway responsiveness.
Discussion
Several nutrients or vitamins with antioxidant or antiinfl ammatory eff ects, acting additively or synergistically, could have benefi cial eff ects on asthma. For example, whereas increased intake of fruits and vegetables decreases the risk of asthma, 30 ,32 a so-called westernised diet-eg, rich in meats, sodium, and refi ned carbohydrates-increased the risk of frequent wheezing. 116 Thus, well designed observational studies and RCTs of particular diets or dietary patterns would be justifi able and of great interest, particularly as a diet rich in fruits and vegetables and low in saturated fats or carbohydrates has known benefi ts to overall health. However, such a diet is not always easy to adhere to because of practical reasons, including cultural beliefs and fi nancial limitations. Specifi c circumstances (such as area of residence, work habits, or fear of being outdoors because of safety concerns [eg, exposure to violence]) could limit sun exposure, which is a main determinant of circulating vitamin D concentrations. Thus, supplementation of benefi cial vitamins or nutrients could be a relatively inexpensive and practical alternative for some populations with asthma or at risk of developing asthma.
All observational studies (cross-sectional and longitudinal) of vitamins or nutrients acting as methyl donors are susceptible to bias due to diff erential entry or retention of participants according to both the exposure and outcome of interest (selection bias), confounding by environmental or lifestyle factors (eg, socioeconomic status, physical activity, intake of other nutrients), and false-positive results due to multiple testing. Additionally, cross-sectional studies are subject to reverse causation (ie, if the disease leads to increased or decreased concentrations of a particular vitamin or nutrient) and recall bias. Furthermore, most observational studies do not have adequate statistical power to test for interactions between the vitamin or nutrient of interest and other dietary components because of the sample sizes usually used in these studies. Despite these limitations, observational studies are often helpful in deciding whether to undertake an RCT and to prioritise the need for a particular RCT. Although RCTs remain the gold standard to determine whether a vitamin or nutrient aff ects asthma, small or poorly conducted trials might be subject to false negatives, residual confounding (eg, if the two groups being compared are not balanced with regard to potential confounders), or bias due to diff erential adherence to treatment or insuffi cient dosing or duration of the intervention of interest.
The fi gure shows some of the potential mechanisms of action of methyl donors and vitamins (A, C, E, and D) on immune responses. Tables 1 and 2 summarise evidence linking vitamins or nutrients acting as methyl donors to asthma or asthma morbidity. Of the four vitamins of interest, data from observational studies support ongoing or future RCTs of vitamin D supplementation for the prevention or treatment of asthma (eg, to prevent severe disease exacerbations). Findings for vitamins A, C, and E best support a large RCT of vitamin E supplementation to ameliorate the detrimental eff ects of air pollution on disease morbidity in patients with asthma. For vitamins A, C, and E, additional follow-up of children in ongoing birth cohort studies could help to prioritise the need for RCTs of primary prevention.
Review
Recommendations for fortifi cation of foods or supplementation of folic acid to women of childbearing age were established after the peak in the asthma epidemic in industrialised countries. This fact, combined with evidence from observational studies, suggests that any eff ect of folate status on development of asthma is likely to be small, and should thus be assessed in the context of ongoing large birth cohort studies, preferably with biomarkers in addition to dietary information. At present, adequate observational studies of folate status and asthma morbidity do not exist. Whereas little evidence exists for a role of vitamin B 12 in the pathogenesis of asthma or asthma morbidity, data from a single RCT support large RCTs of choline supplementation to treat asthma in patients with established disease. In view of existing data, birth cohort studies of choline status and asthma are also justifi ed.
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Search strategy and selection criteria
We searched PubMed for articles published in English from January, 1990, to May, 2013, on vitamins, methyl donors, and asthma. We selected highly relevant articles with the terms "asthma" or "atopy" and "vitamin A" or carotenoids (including carotenes ["α-carotene" or "β-carotene" or "lycopene"] and xanthophylls ["lutein" or "zeaxanthin"]), "vitamin C" or "ascorbic acid", "vitamin D" or "calcitriol", "vitamin E" or "tocopherol", "folate", "vitamin B 12 ", and "choline".
